Skip to Main Content

Author Details

Celina Ang
Tisch Cancer Institute, Mount Sinai Hospital
2005
64
21
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36865801Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.Front Oncol2023
37889520Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.Hepatol Commun2023
37210446Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal Adenocarcinoma.Ann Surg Oncol2023
37005953Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma.Hepatol Int2023
36577703Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.Liver Int2023
35313048Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.Hepatology2022
35710293Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study.J Immunother Cancer2022
35481940Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.Hepatol Commun2022
36497316Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.Cancers (Basel)2022
36148739Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study.Eur J Cancer2022
35986902Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma.Liver Int2022
33417490Cost-Effectiveness Analysis of Selective Internal Radiotherapy With Yttrium-90 Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma.JCO Oncol Pract2021
33568355Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling.Cancer Discov2021
33733072A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinoma.iScience2021
33634858Neoadjuvant therapy for gastrointestinal stromal tumors: A propensity score-weighted analysis.Int J Cancer2021
34950181Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma.Liver Cancer2021
35008350The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma.Cancers (Basel)2021
34964042A single-institutional analysis of racial disparities in clinicopathologic characteristics, treatment selections, and outcomes in advanced-stage pancreatic cancer patients.Ann Pancreat Cancer2021
34508996Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice.Eur J Cancer2021
33995594Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.Ther Adv Med Oncol2021
34032391Impact of pathological response after neoadjuvant chemotherapy on adjuvant therapy decisions and patient outcomes in gastrointestinal cancers.Cancer Rep (Hoboken)2021
32400000A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.Oncologist2020
33283134Lynch Syndrome-Associated Variants and Cancer Rates in an Ancestrally Diverse Biobank.JCO Precis Oncol2020
33028690Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy.J Immunother Cancer2020
32664319Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade.Cancers (Basel)2020
32868393Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study.J Immunother Cancer2020
32419290Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti-PD-1 therapy.Cancer Med2020
31131321A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer.Sci Adv2019
31203390Genistein combined with FOLFOX or FOLFOX-Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study.Cancer Chemother Pharmacol2019
31258846Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma.Oncotarget2019
29628508A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma.Oncogene2018
32913983Genomic Landscape of Appendiceal Neoplasms.JCO Precis Oncol2018
30122687Disparities in Access to Sorafenib in Communities with Low Socioeconomic Status.J Health Care Poor Underserved2018
29691758Gastric adenocarcinoma in young adult patients: patterns of care and survival in the United States.Gastric Cancer2018
27742264Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease.Clin Colorectal Cancer2017
29254188Molecular characteristics of hepatocellular carcinomas from different age groups.Oncotarget2017
28868010Clinical Benefit from Trametinib in a Patient with Appendiceal Adenocarcinoma with a <i>GNAS R201H</i> Mutation.Case Rep Oncol2017
28736645Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer.J Gastrointest Oncol2017
26811636Bisphosphonates as potential adjuvants for patients with cancers of the digestive system.World J Gastroenterol2016
28261637Contemporary Management of Metastatic Gastrointestinal Stromal Tumors: Systemic and Locoregional Approaches.Oncol Ther2016
26661118Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options.J Surg Oncol2016
25678238Role of the fibroblast growth factor receptor axis in cholangiocarcinoma.J Gastroenterol Hepatol2015
24896196CT and MRI of primary and metastatic fibrolamellar carcinoma: a case series of 37 patients.Br J Radiol2014
25155157KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases.Cancer2014
22941024Targeted agents and systemic therapy in hepatocellular carcinoma.Recent Results Cancer Res2013
23898085c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival.Anticancer Res2013
23936551Optimal chemotherapy dosing in a bilateral lower extremities amputee with metastatic pancreatic adenocarcinoma.Gastrointest Cancer Res2013
23936549A 40-year-old woman with locally advanced rectal cancer and a solitary liver metastasis.Gastrointest Cancer Res2013
23748831A case report of a patient with advanced acinar cell carcinoma of the pancreas: long-term survival with regional, systemic and targeted therapy.Tumori2013
23505574A young woman with liver cancer.Gastrointest Cancer Res2013
  • 1 - 50 of 64

Recommended Authors

Nicholas Brian Shannon
Singapore General Hospital
Career Start Year 2010
Number of shared co-authors 0
Ashiq Masood
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Rodrigo Dienstmann
Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2006
Number of shared co-authors 0
Shubham Pant
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 3
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2003
Number of shared co-authors 4
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 1
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Hanneke W M van Laarhoven
Cancer Center Amsterdam
Career Start Year 2001
Number of shared co-authors 0
Itzhak Avital
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 1
Scott Kopetz
University of Texas MD Anderson Cancer Center
Career Start Year 2000
Number of shared co-authors 4
Eric A Collisson
University of California san francisco
Career Start Year 1999
Number of shared co-authors 5
Jennifer A Chan
Dana-Farber Cancer Institute
Career Start Year 1999
Number of shared co-authors 2
Thomas J George
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 4
Antonio Cubillo
Hospital HM Universitario Sanchinarro
Career Start Year 1997
Number of shared co-authors 0
Joon Oh Park
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1997
Number of shared co-authors 3
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Career Start Year 1995
Number of shared co-authors 1
Wells A Messersmith
University of Colorado Anschutz Medical Campus
Career Start Year 1995
Number of shared co-authors 3
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 0
Hideki Ueno
National Defense Medical College
Career Start Year 1993
Number of shared co-authors 0
Oliver F Bathe
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 1
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 6
Suresh Nair
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 1
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Steven R Alberts
Mayo Clinic
Career Start Year 1987
Number of shared co-authors 2
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 2
Al B Benson
Northwestern University Feinberg School of Medicine
Career Start Year 1984
Number of shared co-authors 9
Richard D Schulick
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 1
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 2

Collaborators

Umut Ozbek
Co-authored papers 9
Arndt Vogel
Clinic for Gastroenterology, Medical University Hannover
Co-authored papers 8
Sherri Z Millis
Foundation Medicine Inc
Co-authored papers 4
Richard K G Do
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Siraj M Ali
Foundation Medicine
Co-authored papers 2
Jeffrey S Ross
Foundation Medicine
Co-authored papers 2
Joanne Xiu
Co-authored papers 2
Erin Moshier
Co-authored papers 2
Andrew V Uzilov
University of California Santa Cruz
Co-authored papers 2
Manish A Shah
Weill Cornell University
Co-authored papers 2
Ross L Cagan
University of Glasgow
Co-authored papers 2
Karyn A Goodman
Mount Sinai Hospital
Co-authored papers 2
Eric E Schadt
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Rong Chen
Co-authored papers 2
Robert Sebra
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Madhu Mazumdar
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Sabrina A Suckiel
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Thoetchai Peeraphatdit
University of Nebraska Medical Center
Co-authored papers 1
Joel M Baumgartner
University of California
Co-authored papers 1
David Xu
Co-authored papers 1
Meenhard Herlyn
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers 1
John Paul Shen
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Emily R Soper
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Eric Winquist
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 1
Eimear E Kenny
Icahn School of Medicine at Mount Sinai, NY Institute for Genomic Health
Co-authored papers 1
Avner Schlessinger
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Daniela Sia
Co-authored papers 1
Bart S Ferket
Institute for Healthcare Delivery Science, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Paul T Fanta
University of California San Diego Moores Cancer Center
Co-authored papers 1
Jean-Frederic Colombel
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Release 1.2